|1.||Reader, Al: 20 articles (10/2015 - 10/2003)|
|2.||Beck, Mike: 18 articles (10/2015 - 10/2003)|
|3.||Nusstein, John: 16 articles (10/2015 - 10/2003)|
|4.||Gammaitoni, Arnold R: 16 articles (07/2015 - 12/2002)|
|5.||Dobson, Geoffrey P: 15 articles (04/2015 - 09/2004)|
|6.||Galer, Bradley S: 14 articles (07/2015 - 09/2002)|
|7.||Porreca, Frank: 13 articles (08/2013 - 06/2002)|
|8.||Jensen, Troels S: 12 articles (11/2015 - 01/2002)|
|9.||Drum, Melissa: 12 articles (10/2015 - 01/2010)|
|10.||Baron, Ralf: 12 articles (02/2015 - 11/2003)|
12/01/2014 - "All the described conditions were characterized by a highly intense pain, not adequately controlled by actual medications, which improved after the use of topical lidocaine. "
09/01/2014 - "Based on the literature review, it is not possible to uniformly specify the most effective and safe dose of lidocaine administered intravenously for the treatment of neuropathic or musculoskeletal pain. "
01/01/2011 - "Implants of slow-release lidocaine formulations are most effective against postincisional pain when placed at the ipsilateral nerve innervating the area of incision. "
11/01/2001 - "The purpose of this study was to assess the efficacy of intraarterial lidocaine administration for control of pain resulting from TACE and to evaluate the optimal timing of administration. "
11/01/2013 - "For Qutenza, important predictors of efficacy were efficacy of lidocaine pretreatment and greater pretreatment pain score variability. "
|2.||Neuralgia (Stump Neuralgia)
06/01/2012 - "Quality of life markedly improved in a variety of neuropathic pain conditions and long-term treatment provided sustained relief in patients with neuropathic pain who are responsive to lidocaine plaster. "
07/01/2011 - "Treatment of refractory neuropathic pain with 5% lidocaine-medicated plaster clearly demonstrated efficacy and an excellent safety profile in patients with refractory neuropathic pain."
01/01/2004 - "Because of its proven efficacy and safety profile, the lidocaine patch 5% has been recommended as a first-line therapy for the treatment of the neuropathic pain of PHN."
04/01/2011 - "High-concentration lidocaine was effective in decreasing microglia activation in the CN and in attenuating neuropathic pain sensations at the early stage following nerve injury, when microglia had not yet been activated."
06/01/2012 - "The topical 5% lidocaine medicated plaster is recommended as first-line treatment for localized peripheral neuropathic pain. "
05/01/2007 - "Is intracameral lidocaine really effective in cataract surgery?"
10/01/2007 - "To assess whether preservative-free 1% lidocaine is capable of loosing the junction between the rabbit lens epithelial cells (LECs) and between the cells and capsules and is capable of destroying the LECs, in order to provide scientific basis for pursuing safe and effective drugs to eliminate LECs in cataract surgery and to prevent capsular pacification. "
05/01/1999 - "A single application of lidocaine 2% gel was a safe and effective alternative to multiple topical anesthetic drops for clear corneal cataract surgery. "
01/01/2009 - "Comparative efficacy of topical tetraVisc versus lidocaine gel in cataract surgery."
09/01/2003 - "Efficacy of 2% lidocaine injection as a topical agent in cataract surgery."
07/01/2011 - "Women in lidocaine group perceived a significant reduction in postoperative pain in the first hours after surgery. "
08/01/2013 - "The use of lidocaine in the infiltration solution is effective in postoperative pain control until 18 hours after surgery. "
09/01/2009 - "Intraperitoneal instillation of lidocaine was effective in reducing postoperative pain after minor gynecological laparoscopic procedures."
03/01/2001 - "We conclude that continuous intra-articular and intra-bursal infusion of lidocaine provides effective postoperative pain relief for shoulder arthroscopic surgery."
09/01/2010 - "When compared with lidocaine, it is associated with improved tissue diffusion, rare postoperative complications, and less postoperative pain, thus, representing a safe and effective local anesthetic agent for septoplasty procedure."
06/01/2015 - "The purpose of this study was to determine the effect of 4% buffered lidocaine on the anesthetic success of the inferior alveolar nerve (IAN) block in patients experiencing symptomatic irreversible pulpitis. "
06/01/2015 - "Effect of Buffered 4% Lidocaine on the Success of the Inferior Alveolar Nerve Block in Patients with Symptomatic Irreversible Pulpitis: A Prospective, Randomized, Double-blind Study."
04/01/2015 - "Around 80% of failures have been reported when lignocaine has been used for inferior alveolar nerve block in children and adults with irreversible pulpitis. "
06/01/2015 - "For mandibular posterior teeth, a 4% buffered lidocaine formulation did not result in a statistically significant increase in the success rate or a decrease in injection pain of the IAN block in patients with symptomatic irreversible pulpitis."
04/01/2015 - "The purpose of this study is to compare the anaesthetic efficacy of 4% articaine buccal infiltration and 2% lignocaine inferior alveolar nerve block in children with irreversible pulpitis. "
|5.||Bupivacaine (Bupivacaine Hydrochloride)
|3.||Nerve Block (Nerve Blocks)